Back for good

June 2004

RPL is delighted to welcome Clinical Trials Assistant, Bibbi Jilka back to the company after a short spell at Parexel. Bibbi first joined RPL in 2002, having previously worked with Managing Director, Dr Jörg Täubel and Medical Director, Ulrike Lorch at another company. She returned to RPL after just seven months at Parexel.‘I missed RPL's warm friendly environment. It is really exciting to work within a multidisciplinary team with direct access to the Medical Director and the Head Nurse. I am learning all the time and making the most of my training.’In the turn the RPL Directors are pleased to have Bibbi back. Jörg Täubel said, ‘it's very rewarding to hear that RPL offers a stimulating work environment. We want to develop staff to their maximum potential with good training and as much encouragement as possible. We've known Bibbi for a long time and it's great to have her back.’

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Contributing to our community in 2020

December 17, 2020
Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.
Read more

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 14, 2020
Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.
Read more

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more